2025 Senate Bill 95

Health facilities: hospitals; collection of debts; prohibit if hospital is not in compliance with price transparency laws.

A bill to prohibit hospitals from attempting to collect debts incurred when not in compliance with price transparency laws; and to provide remedies.

AI Analysis – Experimental

Senate Bills 94 and 95 amend the Public Health Code to regulate 340B drug distribution, requiring annual reports from 340B entities and manufacturers on drug costs and compliance.

Introduced in the Senate

Feb. 20, 2025

Introduced by Sen. Jonathan Lindsey (R-17) and eight co-sponsors

Co-sponsored by Sens. Sam Singh (D-28), Joseph Bellino (R-16), John Damoose (R-37), Rick Outman (R-33), Sue Shink (D-14), Stephanie Chang (D-3), Mallory McMorrow (D-8) and Kevin Hertel (D-12)

Referred to the Committee on Oversight

Feb. 27, 2025

Reported without amendment

March 5, 2025

Referred to the Committee of the Whole

Reported without amendment

March 6, 2025

Passed in the Senate 35 to 1 (details)

Received in the House

March 6, 2025

Referred to the Committee on Health Policy

Dec. 10, 2025

Reported with substitute H-3

Dec. 16, 2025

Substitute H-3 concurred in by voice vote

Substitute H-4 offered by Rep. Curtis VanderWall (R-102)

The substitute passed by voice vote

Amendment offered by Rep. Alabas Farhat (D-3)

1. Amend page 11, following line 22, by inserting:

“Enacting section 1. This act does not take effect unless Senate Bill No. 94 of the 103rd Legislature is enacted into law.”.

The amendment failed by voice vote

Passed in the House 106 to 0 (details)

Motion to give immediate effect by Rep. Bryan Posthumus (R-90)

The motion prevailed by voice vote

Received in the Senate

Dec. 23, 2025